• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human FSTL5 Polyclonal Antibody

The antibody against FSTL5 was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 21-250 of human FSTL5 (NP_064501.2) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, IF/ICC, ELISA.

ADA-00214A

The antibody against FSTL5 was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 21-250 of human FSTL5 (NP_064501.2) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, IF/ICC, ELISA.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADA-00214A ClonalityPolyclonal
Host SpeciesRabbitTarget NameFSTL5
Target SynonymsFSTL5FormLiquid
Species ReactivityHuman, Mouse, RatIsotypeIgG
Storage Buffer50% Glycerol, PBS with 0.01% thimerosal, pH7.3.Purification MethodAffinity purification
Positive SamplesMouse brain, Mouse lung, Rat testis, SH-SY5YApplicationELISA, WB, IF/ICC

Immunogen Information


Immunogen DescriptionRecombinant fusion protein containing a sequence corresponding to amino acids 21-250 of human FSTL5 (NP_064501.2).Target SpeciesHuman
Uniprot IDQ8N475Immunogen Sequence
Background Information
  • Uniprot Id

    Q8N475

  • Target Species

    Human

  • Target Name

    FSTL5

  • Target Full Name

    Follistatin-related protein 5

  • Target Subcellular Location

    Secreted.

  • Target Synonyms

    FSTL5; KIAA1263Follistatin-related protein 5; Follistatin-like protein 5

Inquire Rabbit anti-Human FSTL5 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification